Nutrient restriction in combinatory therapy of tumors
- 作者: Senichkin V.V.1, Kopeina G.S.1, Zamaraev A.V.1, Lavrik I.N.1,2, Zhivotovsky B.D.1,3
-
隶属关系:
- Faculty of Basic Medicine
- Department of Translational Inflammation Research
- Institute of Environmental Medicine, Division of Toxicology
- 期: 卷 50, 编号 3 (2016)
- 页面: 362-378
- 栏目: Reviews
- URL: https://journals.rcsi.science/0026-8933/article/view/162655
- DOI: https://doi.org/10.1134/S0026893316030109
- ID: 162655
如何引用文章
详细
The main objective of anticancer treatment is the elimination of degenerated cells by the induction of programmed cell death. Various chemotherapy drugs and radiation are able to activate cell death mechanisms in tumors. However, unfortunately, monotherapy will always be insufficiently effective because of the variety and virulence of tumors, as well as their ability to develop resistance to drugs. Moreover, monotherapy might constrain many negative side effects. Therefore, the combination of different approaches and/or drugs will increase the efficiency of treatment. One such promising approach is the combination of nutrient restriction (NR) and various chemotherapeutic drugs. This approach may not only affect the autophagy but also influence apoptotic cell death. This review is focused on the potential of NR use in anticancer therapy, as well as the molecular mechanisms underlying this approach.
作者简介
V. Senichkin
Faculty of Basic Medicine
Email: Boris.Zhivotovsky@ki.se
俄罗斯联邦, Moscow, 119991
G. Kopeina
Faculty of Basic Medicine
Email: Boris.Zhivotovsky@ki.se
俄罗斯联邦, Moscow, 119991
A. Zamaraev
Faculty of Basic Medicine
Email: Boris.Zhivotovsky@ki.se
俄罗斯联邦, Moscow, 119991
I. Lavrik
Faculty of Basic Medicine; Department of Translational Inflammation Research
Email: Boris.Zhivotovsky@ki.se
俄罗斯联邦, Moscow, 119991; Magdeburg, 39120
B. Zhivotovsky
Faculty of Basic Medicine; Institute of Environmental Medicine, Division of Toxicology
编辑信件的主要联系方式.
Email: Boris.Zhivotovsky@ki.se
俄罗斯联邦, Moscow, 119991; Stockholm, 17177
补充文件
